Omeros Corp SEC filings OMER

Omeros Corp has 810 filings in SEC EDGAR's recent list, going back to Mar 31, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.

Omeros Corp SEC filings
Form Description Filed Period
4 Insider transaction Oct 30, 2026 Oct 28, 2026
8-K Current report
Officer or director change
Oct 30, 2026 Oct 28, 2026
4 Insider transaction Sep 24, 2026 Sep 22, 2026
144 Notice of proposed sale Sep 23, 2026 —
144 Notice of proposed sale Sep 22, 2026 —
4 Insider transaction Sep 1, 2026 Aug 28, 2026
144 Notice of proposed sale Aug 31, 2026 —
144 Notice of proposed sale Aug 28, 2026 —
4 Insider transaction Aug 28, 2026 Aug 26, 2026
144 Notice of proposed sale Aug 27, 2026 —
144 Notice of proposed sale Aug 26, 2026 —
4 Insider transaction Aug 25, 2026 Aug 21, 2026
4 Insider transaction Aug 21, 2026 Aug 20, 2026
144 Notice of proposed sale Aug 21, 2026 —
144 Notice of proposed sale Aug 20, 2026 —
4 Insider transaction Aug 18, 2026 Aug 12, 2026
3 Initial insider ownership Aug 18, 2026 Aug 12, 2026
4 Insider transaction Aug 17, 2026 Aug 13, 2026
144 Notice of proposed sale Aug 13, 2026 —
S-8 Employee stock plan registration Aug 13, 2026 —
8-K Current report
Officer or director change
Aug 13, 2026 Aug 12, 2026
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 29, 2026 —
4 Insider transaction Jul 24, 2026 Jul 22, 2026
4 Insider transaction Jul 24, 2026 Jul 22, 2026
4 Insider transaction Jul 24, 2026 Jul 22, 2026
8-K Current report
Other events
Jul 20, 2026 Jul 20, 2026
8-K Current report
Other events
Jul 6, 2026 Jul 2, 2026
8-K Current report
Shareholder vote results
Jun 25, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
8-K Current report
Other events
Jun 18, 2026 Jun 17, 2026
4 Insider transaction May 27, 2026 May 22, 2026
144 Notice of proposed sale May 22, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 30, 2026 Jun 18, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2026 —
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Feb 20, 2026 Feb 18, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 14, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 13, 2026 —
144 Notice of proposed sale Jan 12, 2026 —
8-K Current report
Results of operations
Jan 7, 2026 Jan 7, 2026
8-K Current report
Other events
Dec 29, 2025 Dec 24, 2025
8-K Current report
Agreement ended, Acquisition or sale of assets, Other events
Dec 1, 2025 Nov 25, 2025
424B5 Prospectus supplement Nov 14, 2025 —
S-3ASR Automatic shelf registration Nov 14, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 31, 2025 —
4 Insider transaction Oct 15, 2025 Oct 13, 2025
8-K Current report
Material agreement, Other events
Oct 15, 2025 Oct 10, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Other events
Jul 25, 2025 Jul 24, 2025
424B5 Prospectus supplement Jul 25, 2025 —
8-K Current report
Shareholder vote results
Jul 2, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
ARS Annual report to shareholders May 30, 2025 Dec 31, 2024
DEF 14A Proxy statement May 30, 2025 Jun 27, 2025
8-K/A Amended current report May 16, 2025 May 12, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale, Other events
May 15, 2025 May 12, 2025
8-K Current report
Other events
May 6, 2025 May 6, 2025
10-K/A Amended annual report Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 31, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 21, 2025 —
8-K Current report
Other events
Feb 20, 2025 Feb 20, 2025
8-K Current report
Other events
Jan 16, 2025 Jan 16, 2025
8-K Current report
Other events
Dec 19, 2024 Dec 19, 2024
10-Q Quarterly report Nov 13, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 13, 2024 Nov 13, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
3 Initial insider ownership Jul 3, 2024 Jun 30, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 12, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
4 Insider transaction Jun 7, 2024 Jun 6, 2024
8-K Current report
Material agreement, New debt, Regulation FD disclosure, Other events
Jun 3, 2024 Jun 3, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
DEF 14A Proxy statement Apr 29, 2024 Jun 6, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
4 Insider transaction Apr 29, 2024 Apr 25, 2024
4 Insider transaction Apr 29, 2024 Apr 25, 2024
4 Insider transaction Apr 29, 2024 Apr 25, 2024
10-K Annual report Apr 1, 2024 Dec 31, 2023
8-K Current report
Results of operations
Apr 1, 2024 Apr 1, 2024
SC 13G/A Amended ownership over 5% (passive) Mar 27, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
8-K Current report
Material agreement, New debt
Feb 7, 2024 Feb 1, 2024
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
4 Insider transaction Nov 21, 2023 Nov 17, 2023
4 Insider transaction Nov 17, 2023 Nov 15, 2023
4 Insider transaction Nov 15, 2023 Nov 13, 2023
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
8-K Current report
Other events
Oct 16, 2023 Oct 16, 2023
4 Insider transaction Sep 27, 2023 Sep 22, 2023
4 Insider transaction Sep 27, 2023 Sep 22, 2023
4 Insider transaction Sep 27, 2023 Sep 22, 2023
144 Notice of proposed sale Sep 20, 2023 —
4 Insider transaction Sep 14, 2023 Sep 12, 2023
S-8 Employee stock plan registration Aug 9, 2023 —
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 28, 2023 Jun 23, 2023
4 Insider transaction Jun 27, 2023 Jun 23, 2023
4 Insider transaction Jun 27, 2023 Jun 23, 2023
4 Insider transaction Jun 27, 2023 Jun 23, 2023
4 Insider transaction Jun 27, 2023 Jun 23, 2023
4 Insider transaction Jun 27, 2023 Jun 23, 2023
4 Insider transaction Jun 27, 2023 Jun 23, 2023
4 Insider transaction May 23, 2023 May 22, 2023
4 Insider transaction May 23, 2023 May 22, 2023
144 Notice of proposed sale May 22, 2023 —
144 Notice of proposed sale May 22, 2023 —
ARS Annual report to shareholders May 17, 2023 Dec 31, 2022
DEF 14A Proxy statement May 17, 2023 Jun 23, 2023
4 Insider transaction May 16, 2023 May 12, 2023
3 Initial insider ownership May 16, 2023 May 12, 2023
8-K Current report
Officer or director change
May 16, 2023 May 12, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
10-K/A Amended annual report May 1, 2023 Dec 31, 2022
10-K Annual report Mar 13, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 13, 2023 Mar 13, 2023
SC 13G/A Amended ownership over 5% (passive) Feb 17, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2023 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
8-K Current report
Results of operations, Other events
Feb 6, 2023 Feb 6, 2023
424B5 Prospectus supplement Nov 18, 2022 —
424B3 Prospectus Nov 18, 2022 —
EFFECT Filing Nov 17, 2022 —
CORRESP Letter to the SEC Nov 16, 2022 —
UPLOAD Letter from the SEC Nov 15, 2022 —
S-3 Shelf registration Nov 9, 2022 —
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 9, 2022 Nov 9, 2022
8-K Current report
Material agreement, New debt
Oct 6, 2022 Sep 30, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
4 Insider transaction Sep 23, 2022 Sep 21, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 9, 2022 Aug 9, 2022
SC 13G Ownership over 5% (passive) Jul 8, 2022 —
8-K Current report
Shareholder vote results
Jun 24, 2022 Jun 17, 2022
4 Insider transaction Jun 22, 2022 Jun 17, 2022
4 Insider transaction Jun 22, 2022 Jun 17, 2022
4 Insider transaction Jun 22, 2022 Jun 17, 2022
4 Insider transaction Jun 22, 2022 Jun 17, 2022
4 Insider transaction Jun 22, 2022 Jun 17, 2022
4 Insider transaction Jun 22, 2022 Jun 17, 2022
4 Insider transaction Jun 22, 2022 Jun 17, 2022
EFFECT Filing May 10, 2022 —
10-Q Quarterly report May 10, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 10, 2022 May 10, 2022
DEF 14A Proxy statement May 2, 2022 Jun 17, 2022
POS AM Filing Mar 1, 2022 —
10-K Annual report Mar 1, 2022 Dec 31, 2021
POSASR Filing Mar 1, 2022 —
8-K Current report
Results of operations
Mar 1, 2022 Mar 1, 2022
4 Insider transaction Feb 14, 2022 Jun 11, 2021
4 Insider transaction Feb 14, 2022 Jun 11, 2021
4 Insider transaction Feb 14, 2022 Jun 11, 2021
4 Insider transaction Feb 14, 2022 Jun 11, 2021

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
OMER (Nasdaq)
Fiscal year ends
December 31
Incorporated in
WA
Headquarters
Seattle, WA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1285819

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.